Dr. Reddy's Laboratories Limited RDY
14.88 USD +0.04 (+0.30%)
As ofNov 20, 2026, 2:33 PM EST
14.88 Day range 15.10
11.36 52-week range 15.67
- YTD
- +5.95%
- 1 year
- +7.01%
News
benzinga.com Gilead Partners With Generic Manufacturers to Boost Future Access to Experimental Ebola Prevention Drug Gilead Sciences signs royalty-free licensing deals with three generic makers to support future Ebola antiviral access across 127 nations.
benzinga.com Dr Reddy's Laboratories Q2 2027 Earnings Call Transcript Dr Reddy’s Laboratories (NYSE:RDY) reported second-quarter financial results on Friday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is…benzinga.com Dr Reddy's Laboratories Q2 EPS $0.12 Misses $0.16 Estimate, Sales $905.000M Miss $980.650M Estimate Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.16 by 25 percent. This is a 36.84 percent decrease over earnings of…
benzinga.com American Express, Eni On Deck Friday As Spending, Energy Demand Face Test American Express headlines Friday’s reports, with premium-card spending and consumer resilience the central questions after a sharp year-to-date stock decline. Eni SpA, SLB, Infosys, First Citizens…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers SCWorx (NASDAQ:WORX) stock rose 47.8% to $3.96 during Tuesday's pre-market session. Integra Lifesciences (NASDAQ:IART) shares increased by 31.97% to $17.75. The market value of their…
